Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
The price of Iovance Biotherapeutics Inc (NASDAQ: IOVA) closed at $5.26 in the last session, down -1.68% from day before closing price of $5.35. In other words, the price has decreased by -$1.68 from its previous closing price. On the day, 12.25 million shares were traded.
Ratios:
We take a closer look at IOVA’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 3.90 and its Current Ratio is at 4.22. In the meantime, Its Debt-to-Equity ratio is 0.10 whereas as Long-Term Debt/Eq ratio is at 0.09.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, UBS on October 24, 2024, initiated with a Buy rating and assigned the stock a target price of $17.
On July 29, 2024, Piper Sandler Downgraded its rating to Neutral which previously was Overweight and also lowered its target price recommendation from $19 to $10.
On November 20, 2023, Goldman started tracking the stock assigning a Buy rating and target price of $12.Goldman initiated its Buy rating on November 20, 2023, with a $12 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Nov 12 ’24 when Maynard Ryan D sold 50,000 shares for $10.06 per share. The transaction valued at 503,000 led to the insider holds 7,500 shares of the business.
Maynard Ryan D bought 50,000 shares of IOVA for $503,104 on Nov 12 ’24.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 17.64 while its Price-to-Book (P/B) ratio in mrq is 2.07.
Stock Price History:
Over the past 52 weeks, IOVA has reached a high of $18.33, while it has fallen to a 52-week low of $5.05. The 50-Day Moving Average of the stock is -17.28%, while the 200-Day Moving Average is calculated to be -39.37%.
Shares Statistics:
A total of 304.62M shares are outstanding, with a floating share count of 247.09M. Insiders hold about 18.93% of the company’s shares, while institutions hold 70.47% stake in the company.
